HR 1188
116th Congress
House
Health
Business records
Drug safety, medical device, and laboratory regulation
Government information and archives
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
FLAT Prices Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 14, 2019
Referred to the Subcommittee on Health.
Feb 13, 2019
Referred to the House Committee on Energy and Commerce.
Feb 13, 2019
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
What's happening now
Referred to the Subcommittee on Health.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 1188: FLAT Prices Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-1188/
"H.R. 1188: FLAT Prices Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-1188/.
H.R. 1188, 116th Cong. (2026), https://openamerica.io/bill/116-HR-1188/.
[H.R. 1188: FLAT Prices Act](https://openamerica.io/bill/116-HR-1188/)